IGC Pharma
23 hedge funds and large institutions have $827K invested in IGC Pharma in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
8% less capital invested
Capital invested by funds: $900K → $827K (-$72.1K)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
23
Holding in Top 10
–
Calls
$49K
Puts
$9K
Top Buyers
| 1 | +$16.4K | |
| 2 | +$4.81K | |
| 3 | +$72 | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$5 |
| 5 |
Goldman Sachs
New York
|
+$3 |
Top Sellers
| 1 | -$28.2K | |
| 2 | -$5.3K | |
| 3 | -$4.23K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$57 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$36 |